Cell Analysis Global Market - Forecast To 2023

 Published On: Jan, 2017 |    No of Pages: 526 |  Published By: IQ4I Research and Consultancy | Format: PDF
Request Free Sample
Cells are the biological units that are used for the identification and mapping of the basic biochemical and physical processes of life. Analysis of these cells plays a major role in gene identification, protein identification, transcription analysis and epigenomics at the cellular level by revealing the heterogenocity of the the cells. Hospitals, academic institutions, government institutes, as well as pharmaceutical and biotechnology firms are increasing their focus on the application of cell analysis as a modern emerging tool in research, drug discovery and diagnosis. The cell analysis techniques global market is segmented into molecular approaches and image-based approaches. The molecular approaches include the PCR, sequencing techniques, microarray and microfluidics, cell isolation and separation techniques performed at cells genomic level. Real-time PCR and Digital PCR are the two PCR techniques. Sequencing techniques are segmented into DNA sequencing, RNA sequencing, and protein sequencing. Cell isolation and separation techniques include centrifugation, cell surface based separation, filtration based cell separation and other separation techniques. Microcentrifugation, high-speed centrifugation, and ultracentrifugation are the types of the centrifugation process. Among molecular approaches PCR accounted for the largest share and sequencing is expected to grow at highest CAGR from 2016-2023.

This image-based approach of cell analysis technology global market is segmented into microscopy, cytometry, high content screening, FISH, and Spectrophotometers. Microscopy types are optical microscopy, electron microscopy and scanning probe microscopy (SPM). Under optical microscopy, the types are fluorescence microscopy and confocal microscopy. Stimulated Emission Depletion (STED), Total Internal Reflection Fluorescence (TIRF), Fluorescence Recovery after Photobleaching (FRAP) and Laser Capture Microdissection are the types of fluorescence microscopy.  Under electron microscopy, the types are Scanning Electron Microscope (SEM), Transmission Electron Microscopy (TEM) and Cryo-Electron Tomography (Cryo-ET). Among image based approaches Cytometry generated the largest revenue and FISH is expected to grow at double digit CAGR from 2016-2023.   

The cell analysis products market is mainly segmented into consumables, instruments, software and services. The consumables include reagents, assay plates, microplates, cell culture consumables and others. The instrument segment comprises of cell counters, microscopes, cell isolation and separation instruments, cytometers, spectrophotometer, Sequencing instruments, PCR devices, microfluidic devices, high content screening (HCS) systems and cell microarrays. Cell counters types are hemocytometers, automated cell counters, coulter counters and others cell counters. Cytometers types are flow cytometers, laser scanning cytometer, and imaging cytometer. Spectrophotometers include microplate readers, fluorescent spectrophotometers and calorimeters. Microscopes types are electron microscopes, inverted microscopes, stereo microscopes, fluorescence and confocal microscopes, phase contrast microscopes and other microscopes.

By application, the market is segmented into by processes, by field, and by therapeutic area. By process of application, the market is segmented into cellular processes, signal transduction pathways, circulating tumor cells, single cell analysis, epigenetic target analysis, subpopulation characterization, and drug and candidate screening. Cellular process application accounted for a largest revenue and the single cell analysis market is expected to boom at a high CAGR from 2016-2023. By field of application, the market is further segmented into forensic, therapeutics, cell imaging, biomarker research, genomic analysis, stem cell analysis, and diagnostics. Diagnostics is holding the largest revenue in 2016 and stem cell analysis is expected to grow at a high CAGR from 2016-2023. By therapeutic area, the market is further segmented into cancer research, infectious disease diagnosis, genetic testing, immunology, and others. The immunology accounted for largest revenue in 2016 and genetic testing is expected to grow at a strong CAGR from 2016-2023.

By end-users, the market is segmented into hospitals, academic and research institutes, contract research organizations (CROs), pharmaceuticals and biotechnology companies, cell banks, diagnostic laboratories and others. Academic and research institutes generated the largest revenue in 2016 and the Contract Research Organizations are expected to grow at high CAGR from 2016-2023

By geography, the market is segmented into North America, Europe, Asia-Pacific and Rest of World. North America holds the largest market share in 2016, followed by Europe and Asia. The APAC regions tend to be an emerging market with an opportunity for growth with a highest CAGR from 2016-2023 and are likely to be a destination of investment for new investors in the cell analysis market. Drug discovery services outsourcing and government funding for novel screening technologies have resulted in a growth of Asian markets.

The cell analysis market is expected to grow at high single digit CAGR to reach $47,088 million by 2023. The major factor influencing the growth is enhanced precision of cell imaging and analysis systems which in turn reduce time and cost of drug discovery process. In addition, the factors like increasing incidence of cancer, increasing government investments, funds, and grants, availability of reagents and cell analysis instruments are driving the growth of the market. However, the major market restraints include high capital investments and a shortage of skilled labor for the high content screening procedure. The biggest opportunities for this market is the emerging APAC market, high content screening services provided by contract research organizations, automation in cancer research for its early diagnosis and reduction of cost in the cancer treatment.

The cell analysis global market is a competitive and all the active players in this market are involved in innovating new and advanced products to maintain their market shares. The key players in the cell analysis global market include Agilent Technologies, Inc. (U.S.), Becton Dickinson and Company (U.S.), Bio-Rad Laboratories (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.K.), Merck KGAA (Germany), Olympus Corporation (Japan), PerkinElmer, Inc. (U.S.), Promega Corporation (U.S.), Qiagen N.V. (Netherlands) and ThermoFisher Scientific, Inc. (U.S.). In order to offer the products with better software, most of the players in the cell analysis market are collaborating with companies and educational institutions.

The report provides an in depth market analysis of the above mentioned segments across the following regions:
ē North America
ē Europe
ē Asia-Pacific
ē Rest of the World (RoW)
1 EXECUTIVE SUMMARY 29
2 INTRODUCTION 40
2.1 KEY TAKE AWAYS 40
2.2 REPORT DESCRIPTION 40
2.3 MARKETS COVERED 43
2.4 STAKEHOLDERS 46
2.5 RESEARCH METHODOLOGY 47
2.5.1 MARKET SIZE ESTIMATION 48
2.5.2 MARKET BREAKDOWN & DATA TRIANGULATION 51
2.5.3 SECONDARY SOURCES 52
2.5.4 KEY DATA POINTS FROM SECONDARY SOURCES 53
2.5.5 PRIMARY SOURCES 53
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 54
2.5.7 ASSUMPTIONS 54
3 MARKET ANALYSIS 56
3.1 INTRODUCTION 56
3.2 MARKET SEGMENTATION 57
3.3 FACTORS INFLUENCING MARKET 60
3.3.1 DRIVERS AND OPPORTUNITIES 61
3.3.1.1 Rising incidence of life threatening infectious diseases 61
3.3.1.2 Increasing government, corporate funding and  investment in cell
based research 61
3.3.1.3 Introduction of enhanced cell imaging and analysis system reduces the
cost and time consumption for drug discovery process 62
3.3.1.4 Availability of advanced cell analysis instruments 63
3.3.1.5 Increasing demand for cell analysis products by  end users 64
3.3.1.6 Emerging asia pacific cell analysis market 65
3.3.1.7 Increased availability of cell analysis service providers 66
3.3.1.8 Automation in oncology research for early  diagnosis 67
3.3.2 RESTRAINTS & THREATS 68
3.3.2.1 Lack of skilled personnel to perform high  content screening 68
3.3.2.2 Expensive cell analysis instruments 68
3.3.2.3 Stringent regulatory framework limits advancements in 
cellular analysis market 69
3.3.2.4 Patents or IPR issues hindering the cell analysis market 70
3.4 REGULATORY AFFAIRS 71
3.4.1 U.S. 71
3.4.2 EUROPE 72
3.4.3 CHINA 74
3.4.4 INDIA 74
3.4.5 JAPAN 74
3.5 PORTERíS FIVE FORCE ANALYSIS 75
3.5.1 THREAT OF NEW ENTRANTS 76
3.5.2 THREAT OF SUBSTITUTES 77
3.5.3 COMPETITIVE RIVALRY 78
3.5.4 BARGAINING POWER OF SUPPLIERS 78
3.5.5 BARGAINING POWER OF BUYERS 79
3.6 LATEST AND UPCOMING PRODUCTS 80
3.7 ONGOING RESEARCHES AND FUNDING SCENARIO 85
3.8 SUPPLY CHAIN ANALYSIS 87
3.9 LIVE CELL IMAGING 90
3.10 MARKET SHARE ANALYSIS 92
3.10.1 MARKET SHARE ANALYSIS BY CELL ANALYSIS MAJOR PLAYERS 92
3.10.2 MARKET SHARE ANALYSIS BY SINGLE CELL ANALYSIS MAJOR PLAYERS 96
4 CELL ANALYSIS GLOBAL MARKET, BY TECHNIQUES 98
4.1 INTRODUCTION 98
4.2 MOLECULAR APPROACHES 103
4.2.1 PCR (POLYMERASE CHAIN REACTION) 106
4.2.2 SEQUENCING 110
4.2.3 MICROFLUIDICS AND MICROARRAYS 116
4.2.3.1 Microfluidics 119
4.2.3.2 Microarray 122
4.2.4 CELL ISOLATION AND SEPARATION 124
4.3 IMAGE BASED APPROACHES 131
4.3.1 MICROSCOPY 134
4.3.2 CYTOMETRY 146
4.3.3 HIGH CONTENT SCREENING 150
4.3.4 FISH (FLUOROSCENCE IN-SITU HYBRIDIZATION) 153
4.3.5 SPECTROPHOTOMETRY 155
5 CELL ANALYSIS GLOBAL MARKET, BY PRODUCTS 157
5.1 INTRODUCTION 157
5.2 CONSUMABLES 160
5.2.1 ASSAY KITS 163
5.2.2 REAGENTS 169
5.2.3 MICROPLATES 171
5.2.4 CELL CULTURE CONSUMABLES 173
5.2.5 OTHERS 175
5.3 INSTRUMENTS 178
5.3.1 CELL COUNTERS 181
5.3.2 CELL MICROARRAYS 187
5.3.3 CELL ISOLATION AND SEPERATION INSTRUMENTS 189
5.3.4 CYTOMETERS 191
5.3.5 HIGH CONTENT SCREENING SYSTEMS 197
5.3.6 MICROFLUIDIC DEVICES 200
5.3.7 PCR INSTRUMENTS 202
5.3.8 SEQUENCING INSTRUMENTS 207
5.3.9 SPECTROPHOTOMETERS 211
5.3.10 MICROSCOPES 216
5.3.11 OTHER INSTRUMENTS 223
5.4 SOFTWARES AND SERVICES 225
6 CELL ANALYSIS GLOBAL MARKET, BY APPLICATION 228
6.1 INTRODUCTION 228
6.2 CELL ANALYSIS GLOBAL MARKET, BY PROCESS OF APPLICATION 229
6.2.1 CELLULAR PROCESSES 232
6.2.2 SIGNAL TRANSDUCTION PATHWAY 234
6.2.3 CIRCULATING TUMOR CELLS 236
6.2.4 SINGLE CELL ANALYSIS 238
6.2.5 EPIGENETIC TARGET ANALYSIS 241
6.2.6 SUBPOPULATION CHARACTERIZATION 244
6.2.7 DRUG AND CANDIDATE SCREENING 246
6.3 CELL ANALYSIS GLOBAL MARKET, BY FIELD OF APPLICATION 248
6.3.1 FORENSICS 251
6.3.2 THERAPEUTICS 253
6.3.3 GENOMIC ANALYSIS 255
6.3.4 STEM CELL ANALYSIS 257
6.3.5 BIOMARKER RESEARCH 259
6.3.6 CELL IMAGING 261
6.3.7 DIAGNOSTICS 263
6.4 CELL ANALYSIS GLOBAL MARKET, BY THERAPEUTIC AREA OF
 APPLICATIONS 265
6.4.1 CANCER RESEARCH 268
6.4.2 GENETIC TESTING 271
6.4.3 INFECTIOUS DISEASES 273
6.4.4 IMMUNOLOGY 276
6.4.5 OTHERS 278
7 CELL ANALYSIS GLOBAL MARKET, BY END-USERS 281
7.1 INTRODUCTION 281
7.2 HOSPITALS 283
7.3 ACADEMIC & RESEARCH LABORATORIES 285
7.4 DIAGNOSTIC LABORATORIES 288
7.5 PHARMACEUTICALS AND BIOTECH COMPANIES 289
7.6 CONTRACT RESEARCH ORGANISATIONS 291
7.7 CELL BANKS 293
7.8 OTHERS 295
8 REGIONAL MARKET ANALYSIS 297
8.1 INTRODUCTION 297
8.2 NORTH AMERICA 298
8.3 EUROPE 314
8.4 ASIA PACIFIC 331
8.5 REST OF THE WORLD 350
9 COMPANY DEVELOPMENTS 367
9.1 INTRODUCTION 367
9.1.1 NEW PRODUCT LAUNCH AS A MAJOR GROWTH STRATEGY OF CELL ANALYSIS MARKET PLAYERS 368
9.2 NEW PRODUCT LAUNCH 368
9.3 AGREEMENTS PARTERNER SHIPS, COLLABORATIONS & JOINT VENTURES 384
9.4 MERGERS AND ACQUISITIONS 390
9.5 APPROVAL 394
9.6 BUSINESS EXPANSION 396
10 MAJOR PLAYER PROFILES 399
10.1 AGILENT TECHNOLOGIES, INC. 399
10.1.1 OVERVIEW 399
10.1.2 FINANCIALS 400
10.1.3 PRODUCT PORTFOLIO 402
10.1.4 KEY DEVELOPMENTS 408
10.1.5 BUSINESS STRATEGY 412
10.1.6 SWOT ANALYSIS 413
10.2 BECKTON DICKENSON AND COMPANY 414
10.2.1 OVERVIEW 414
10.2.2 FINANCIALS 415
10.2.3 PRODUCT PORTFOLIO 418
10.2.4 KEY DEVELOPMENTS 420
10.2.5 BUSINESS STRATEGY 422
10.2.6 SWOT ANALYSIS 424
10.3 BIO-RAD LABORATORIES 425
10.3.1 OVERVIEW 425
10.3.2 FINANCIALS 426
10.3.3 PRODUCT PORTFOLIO 428
10.3.4 KEY DEVELOPMENTS 431
10.3.5 BUSINESS STRATEGY 432
10.3.6 SWOT ANALYSIS 434
10.4 DANAHER CORPORATION 435
10.4.1 OVERVIEW 435
10.4.2 FINANCIALS 436
10.4.3 PRODUCT PORTFOLIO 438
10.4.4 KEY DEVELOPMENTS 445
10.4.5 BUSINESS STRATEGY. 446
10.4.6 SWOT ANALYSIS 447
10.5 GE HEALTHCARE 448
10.5.1 OVERVIEW 448
10.5.2 FINANCIALS 449
10.5.3 PRODUCT PORTFOLIO 451
10.5.4 KEY DEVELOPMENTS 456
10.5.5 BUSINESS STRATEGY 458
10.5.6 SWOT ANALYSIS 459
10.6 MERCK KGAA 460
10.6.1 OVERVIEW 460
10.6.2 FINANCIALS 461
10.6.3 PRODUCT PORTFOLIO 464
10.6.4 KEY DEVELOPMENTS 467
10.6.5 BUSINESS STRATEGY 469
10.6.6 SWOT ANALYSIS 470
10.7 OLYMPUS CORPORATION 471
10.7.1 OVERVIEW 471
10.7.2 FINANCIALS 472
10.7.3 PRODUCT PORTFOLIO 475
10.7.4 KEY DEVELOPMENTS 476
10.7.5 BUSINESS STRATEGY 479
10.7.6 SWOT ANALYSIS 480
10.8 PERKINELMER, INC. 481
10.8.1 OVERVIEW 481
10.8.2 FINANCIALS 482
10.8.3 PRODUCT PORTFOLIO 484
10.8.4 KEY DEVELOPMENTS 488
10.8.5 BUSINESS STRATEGY 489
10.8.6 SWOT ANALYSIS 490
10.9 PROMEGA CORPORATION 491
10.9.1 OVERVIEW 491
10.9.2 FINANCIALS 492
10.9.3 PRODUCT PORTFOLIO 492
10.9.4 KEY DEVELOPMENTS 496
10.9.5 BUSINESS STRATEGY 498
10.9.6 SWOT ANALYSIS 499
10.10 QIAGEN N V 500
10.10.1 OVERVIEW 500
10.10.2 FINANCIALS 501
10.10.3 PRODUCT PORTFOLIO 503
10.10.4 KEY DEVELOPMENTS 510
10.10.5 BUSINESS STRATEGY 515
10.10.6 SWOT ANALYSIS 516
10.11 THERMOFISHER SCIENTIFIC INC. 517
10.11.1 OVERVIEW 517
10.11.2 FINANCIALS 518
10.11.3 PRODUCT PORTFOLIO 520
10.11.4 KEY DEVELOPMENTS 524
10.11.5 BUSINESS STRATEGY 526
10.11.6 SWOT ANALYSIS 527

LIST OF TABLES

TABLE 1 CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN) 31
TABLE 2 CELL ANALYSIS GLOBAL MARKET REVENUE,    BY TECHNIQUE, (2015-2023) ($MN) 32
TABLE 3 CELL ANALYSIS GLOBAL MARKET REVENUE,  BY PRODUCTS, (2015-2023) ($MN) 33
TABLE 4 CELL ANALYSIS GLOBAL MARKET REVENUE,  BY PROCESS OF APPLICATION (2015-2023) ($MN) 34
TABLE 5 CELL ANALYSIS GLOBAL MARKET REVENUE,  BY FIELD OF APPLICATION (2015-2023) ($MN) 35
TABLE 6 CELL ANALYSIS GLOBAL MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATION (2015-2023) ($MN) 36
TABLE 7 CELL ANALYSIS GLOBAL MARKET REVENUE, BY END USERS, (2015-2023) ($MN) 37
TABLE 8 CELL ANALYSIS GLOBAL TECHNIQUES MARKET REVENUE,  BY REGION, (2015-2023) ($MN) 99
TABLE 9 CELL ANALYSIS GLOBAL MARKET REVENUE, BY TECHNIQUE,  (2015-2023) ($MN) 100
TABLE 10 MOLECULAR BASED CELL ANALYSIS APPROACH GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN) 103
TABLE 11 MOLECULAR BASED CELL ANALYSIS GLOBAL MARKET REVENUE,  BY TYPE, (2015-2023) ($MN)  104
TABLE 12 PCR TECHNIQUE IN CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN) 105
TABLE 13 SEQUENCING TECHNIQUE IN CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN) 109
TABLE 14 MICROFLUIDICS AND MICROARRAY IN CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN) 116
TABLE 15 MICROFLUIDIC AND MICROARRAY IN CELL ANALYSIS GLOBAL MARKET REVENUE, BY TYPES, (2015-2023) ($MN) 117
TABLE 16 MICROFLUIDICS IN CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN) 119
TABLE 17 MICROARRAYS IN CELL ANALYSIS GLOBAL MARKET REVENUE,  BY REGION, (2015-2023) ($MN) 122
TABLE 18 CELL ISOLATION AND SEPERATION IN CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN) 123
TABLE 19 IMAGE-BASED CELL ANALYSIS APPROACHES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN) 131
TABLE 20 IMAGE BASED CELL ANALYSIS APPROACH GLOBAL MARKET REVENUE, BY TYPES, (2015-2023) ($MN) 132
TABLE 21 MICROSCOPY CELL ANALYSIS GLOBAL MARKET REVENUE,  BY REGION, (2015-2023) ($MN) 134
TABLE 22 CYTOMETRY CELL ANALYSIS GLOBAL MARKET REVENUE,  BY REGION, (2015-2023) ($MN) 145
TABLE 23 HIGH CONTENT SCREENING CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN) 150
TABLE 24 FISH (FLUORESCENT IN-SITU HYBRIDIZATION) CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN) 152
TABLE 25 SPECTROPHOTOMETRY CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN) 154
TABLE 26 CELL ANALYSIS GLOBAL MARKET, BY PRODUCTS  (2015-2023) ($MN) 158
TABLE 27 CELL ANALYSIS CONSUMABLES GLOBAL MARKET, BY REGION  (2015-2023) ($MN) 160
TABLE 28 CELL ANALYSIS GLOBAL MARKET, BY CONSUMABLES  (2015-2023) ($MN) 161
TABLE 29 CELL ANALYSIS ASSAY KITS GLOBAL MARKET,  BY REGION (2015-2023) ($MN) 165
TABLE 30 CELL ANALYSIS REAGENTS GLOBAL MARKET, BY REGION  (2015-2023) ($MN) 169
TABLE 31 CELL ANALYSIS MICROPLATES GLOBAL MARKET, BY REGION  (2015-2023) ($MN) 171
TABLE 32 CELL ANALYSIS CONSUMABLES GLOBAL MARKET FOR CELL CULTURE, BY REGION (2015-2023) ($MN) 173
TABLE 33 CELL ANALYSIS OTHER CONSUMABLES GLOBAL MARKET,  BY REGION (2015-2023) ($MN) 176
TABLE 34 CELL ANALYSIS INSTRUMENTS GLOBAL MARKET, BY REGION  (2015-2023) ($MN) 178
TABLE 35 CELL ANALYSIS INSTRUMENTS GLOBAL MARKET,  BY TYPE (2015-2023) ($MN) 179
TABLE 36 CELL COUNTERS IN CELL ANALYSIS GLOBAL MARKET, BY REGION  (2015-2023) ($MN) 181
TABLE 37 CELL ANALYSIS CELL MICROARRAYS GLOBAL MARKET, BY REGION  (2015-2023) ($MN) 187
TABLE 38 CELL ANALYSIS CELL ISOLATION/ SEPARATION INSTRUMENTS GLOBAL MARKET, BY REGION (2015-2023) ($MN) 189
TABLE 39 CELL ANALYSIS CYTOMETERS GLOBAL MARKET, BY REGION  (2015-2023) ($MN) 191
TABLE 40 CELL ANALYSIS GLOBAL MARKET FOR HIGH CONTENT SCREENING DEVICES, BY REGION (2015-2023) ($MN) 197
TABLE 41 CELL ANALYSIS GLOBAL MARKET FOR MICROFLUIDIC DEVICES, BY REGION (2015-2023) ($MN) 200
TABLE 42 CELL ANALYSIS MARKET FOR PCR DEVICES, BY REGION  (2015-2023) ($MN) 205
TABLE 43 CELL ANALYSIS SEQUENCING GLOBAL MARKET, BY REGION (2015-2023) ($MN) 209
TABLE 44 CELL ANALYSIS SPECTROPHOTOMETERS GLOBAL MARKET,  BY REGION (2015-2023) ($MN) 211
TABLE 45 CELL ANALYSIS MICROSCOPY GLOBAL MARKET, BY REGION  (2015-2023) ($MN) 216
TABLE 46 CELL ANALYSIS OTHER INSTRUMENTS GLOBAL MARKET, BY REGION (2015-2023) ($MN) 223
TABLE 47 CELL ANALYSIS SOFTWARES AND SERVICES PRODUCTS GLOBAL MARKET, BY REGION (2015-2023) ($MN) 225
TABLE 48 CELL ANALYSIS GLOBAL MARKET, BY PROCESS OF APPLICATION, (2015-2023) ($MN) 230
TABLE 49 CELL ANALYSIS APPLICATION GLOBAL MARKET FOR CELLULAR PROCESSES, BY REGION, (2015-2023) ($MN) 232
TABLE 50 CELL ANALYSIS APPLICATION GLOBAL MARKET FOR SIGNAL TRANSDUCTION STUDIES, BY REGION (2015-2023) ($MN) 234
TABLE 51 CELL ANALYSIS APPLICATIONS GLOBAL MARKET FOR CTC, BY REGION (2015-2023) ($MN) 236
TABLE 52 CELL ANALYSIS APPLICATIONS GLOBAL MARKET FOR SINGLE CELL ANALYSIS, BY REGION (2015-2023) ($MN) 239
TABLE 53 CELL ANALYSIS APPLICATIONS GLOBAL MARKET FOR EPIGENETIC TARGET ANALYSIS, BY REGION (2015-2023) ($MN) 242
TABLE 54 CELL ANALYSIS APPLICATIONS GLOBAL MARKET FOR SUBPOPULATION CHARACTERIZATION,  BY REGION (2015-2023) ($MN) 244
TABLE 55 CELL ANALYSIS APPLICATIONS GLOBAL MARKET FOR DRUG AND CANDITATE SCREENING, BY REGION (2015-2023) ($MN) 246
TABLE 56 CELL ANALYSIS GLOBAL MARKET, BY FIELD OF APPLICATION, (2015-2023) ($MN) 249
TABLE 57 CELL ANALYSIS APPLICATION GLOBAL MARKET IN FORENSICS,  BY REGION, (2015-2023) ($MN) 251
TABLE 58 CELL ANALYSIS APPLICATION GLOBAL MARKET IN THERAPEUTICS, BY REGION (2015-2023) ($MN) 253
TABLE 59 CELL ANALYSIS APPLICATIONS GLOBAL MARKET FOR GENOMIC ANALYSIS, BY REGION (2015-2023) ($MN) 255
TABLE 60 CELL ANALYSIS APPLICATIONS GLOBAL MARKET FOR STEM CELL ANALYSIS, BY REGION (2015-2023) ($MN) 257
TABLE 61 CELL ANALYSIS APPLICATIONS GLOBAL MARKET FOR BIOMARKER RESEARCH, BY REGION (2015-2023) ($MN) 259
TABLE 62 CELL ANALYSIS APPLICATIONS GLOBAL MARKET FOR CELL IMAGING,BY REGION (2015-2023) ($MN) 261
TABLE 63 CELL ANALYSIS APPLICATIONS GLOBAL MARKET FOR DIAGNOSTICS, BY REGION (2015-2023) ($MN) 263
TABLE 64 CELL ANALYSIS GLOBAL MARKET REVENUE,  BY THERAPEUTIC AREA OF APPLICATION, (2015-2023) ($MN) 266
TABLE 65 CELL ANALYSIS APPLICATION GLOBAL MARKET FOR CANCER RESEARCH, BY REGION, (2015-2023) ($MN) 269
TABLE 66 CELL ANALYSIS APPLICATION GLOBAL MARKET FOR GENETIC TESTING, BY REGION (2015-2023) ($MN) 271
TABLE 67 CELL ANALYSIS APPLICATIONS GLOBAL MARKET FOR INFECTIOUS DISEASES, BY REGION (2015-2023) ($MN) 274
TABLE 68 CELL ANALYSIS APPLICATIONS GLOBAL MARKET FOR IMMUNOLOGY, BY REGION (2015-2023) ($MN) 276
TABLE 69 CELL ANALYSIS APPLICATIONS GLOBAL MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION  (2015-2023) ($MN) 278
TABLE 70 CELL ANALYSIS GLOBAL MARKET REVENUE, BY ENDUSERS,  (2015-2023) ($MN) 281
TABLE 71 HOSPITALS CELL ANALYSIS GLOBAL MARKET REVENUE,  BY REGION, (2015-2023) ($MN) 283
TABLE 72 ACADEMICS & RESEARCH LABORATORIES CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN) 285
TABLE 73 CELL ANALYSIS GLOBAL MARKET REVENUE FROM DIAGNOSTIC LABORATORIES, BY REGION, (2015-2023) ($MN) 287
TABLE 74 CELL ANALYSIS GLOBAL MARKET REVENUE FROM PHARMA & BIOTECH COMPANIES, BY REGION, (2015-2023) ($MN) 289
TABLE 75 CELL ANALYSIS GLOBAL MARKET REVENUE FROM CROíS,  BY REGION, (2015-2023) ($MN) 291
TABLE 76 CELL ANALYSIS GLOBAL MARKET REVENUE FROM CELL BANKS,  BY REGION, (2015-2023) ($MN) 293
TABLE 77 CELL ANALYSIS GLOBAL MARKET REVENUE FROM OTHER END USERS, BY REGION, (2015-2023) ($MN) 294
TABLE 78 NORTH AMERICAN CELL ANALYSIS MARKET REVENUE,  BY TECHNIQUES, (2015-2023) ($MN) 302
TABLE 79 NORTH AMERICAN MOLECULAR CELL ANALYSIS APPROACHES MARKET REVENUE, BY TYPES, (2015-2023) ($MN) 303
TABLE 80 NORTH AMERICAN MICROFLUIDICS AND MICROARRAY TECHNIQUES MARKET REVENUE, BY TYPES, (2015-2023) ($MN) 304
TABLE 81 NORTH AMERICAN IMAGE BAESD CELL ANALYSIS MARKET REVENUE, BY TYPES, (2015-2023) ($MN)  305
TABLE 82 NORTH AMERICAN CELL ANALYSIS MARKET REVENUE,  BY PRODUCTS (2015-2023) ($MN) 306
TABLE 83 NORTH AMERICAN CELL ANALYSIS MARKET REVENUE,  BY CONSUMABLES, (2015-2023) ($MN) 307
TABLE 84 NORTH AMERICAN CELL ANALYSIS MARKET REVENUE,  BY INSTRUMENTS, (2015-2023) ($MN)  308
TABLE 85 NORTH AMERICAN CELL ANALYSIS MARKET REVENUE,  BY PROCESS OF APPLICATION, (2015-2023) ($MN)  309
TABLE 86 NORTH AMERICAN  CELL ANALYSIS MARKET REVENUE, BY FIELDS OF APPLICATION, (2015-2023) ($MN)  310
TABLE 87 NORTH AMERICAN  MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATION, (2015-2023) ($MN)  311
TABLE 88 NORTH AMERICAN CELL ANALYSIS MARKET REVENUE,  BY END USERS, (2015-2023) ($MN) 312
TABLE 89 EUROPE CELL ANALYSIS MARKET REVENUE,  BY TECHNIQUES, (2015-2023) ($MN) 319
TABLE 90 EUROPE MOLECULAR BASED CELL ANALYSIS APPROACH MARKET REVENUE, BY TYPES, (2015-2023) ($MN) 320
TABLE 91 EUROPE MICROFLUIDICS AND MICROARRAY TECHNIQUES MARKET REVENUE, BY TYPES, (2015-2023) ($MN) 321
TABLE 92 EUROPE IMAGE BASED CELL ANALYSIS APPROACH  MARKET REVENUE, BY TYPES, (2015-2023) ($MN)  322
TABLE 93 EUROPE CELL ANALYSIS MARKET REVENUE, BY PRODUCTS  (2015-2023) ($MN) 323
TABLE 94 EUROPE CELL ANALYSIS MARKET REVENUE,  BY CONSUMABLES, (2015-2023) ($MN) 324
TABLE 95 EUROPE CELL ANALYSIS MARKET REVENUE,  BY INSTRUMENTS, (2015-2023) ($MN)  325
TABLE 96 EUROPE CELL ANALYSIS MARKET REVENUE,  BY PROCESS OF APPLICATION, (2015-2023) ($MN)  326
TABLE 97 EUROPE CELL ANALYSIS MARKET REVENUE,  BY FIELD OF APPLICATION, (2015-2023) ($MN)  327
TABLE 98 EUROPE  CELL ANALYSIS MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATION, (2015-2023) ($MN)  328
TABLE 99 EUROPE CELL ANALYSIS MARKET REVENUE, BY ENDUSERS,  (2015-2023) ($MN) 329
TABLE 100 ASIA PACIFIC CELL ANALYSIS MARKET REVENUE,  BY TECHNIQUES, (2015-2023) ($MN) 337
TABLE 101 ASIA PACIFIC MOLECULAR BASED CELL ANALYSIS APPROACH MARKET REVENUE, BYTYPE, (2015-2023) ($MN) 338
TABLE 102 ASIA PACIFIC MICROFLUIDICS AND MICROARRAY TECHNIQUES MARKET REVENUE, BY TYPES, (2015-2023) ($MN) 339
TABLE 103 ASIA PACIFIC IMAGE BASED CELL ANALYSIS APPROACH MARKET REVENUE, BY TYPES, (2015-2023) ($MN)  340
TABLE 104 ASIA PACIFIC CELL ANALYSIS MARKET REVENUE,  BY PRODUCTS (2015-2023) ($MN) 341
TABLE 105 ASIA PACIFIC CELL ANALYSIS MARKET REVENUE,  BY CONSUMABLES, (2015-2023) ($MN) 342
TABLE 106 ASIA PACIFIC CELL ANALYSIS MARKET REVENUE,  BY INSTRUMENTS, (2015-2023) ($MN)  343
TABLE 107 ASIA PACIFIC CELL ANALYSIS MARKET REVENUE, BY PROCESS OF APPLICATIONS, (2015-2023) ($MN)  344
TABLE 108 ASIA PACIFIC  CELL ANALYSIS MARKET REVENUE, BY FIELDS OF APPLICATION, (2015-2023) ($MN)  345
TABLE 109 ASIA PACIFIC  CELL ANALYSIS MARKET REVENUE,  BY THERAPEUTIC AREA OF APPLICATION, (2015-2023) ($MN)  346
TABLE 110 ASIA PACIFIC CELL ANALYSIS MARKET REVENUE,  BY ENDUSERS, (2015-2023) ($MN) 347
TABLE 111 ROW  CELL ANALYSIS MARKET REVENUE,  BY TECHNIQUES, (2015-2023) ($MN) 354
TABLE 112 ROW  MOLECULAR BASED CELL ANALYSIS APPROACH MARKET REVENUE, BY TYPES, (2015-2023) ($MN) 355
TABLE 113 ROW  MICROFLUIDICS AND MICROARRAY TECHNIQUES MARKET REVENUE, BY TYPES, (2015-2023) ($MN) 356
TABLE 114 ROW  IMAGE BASED CELL ANALYSIS APPROACH MARKET REVENUE, BY TYPES, (2015-2023) ($MN)  357
TABLE 115 ROW  CELL ANALYSIS MARKET REVENUE,  BY PRODUCTS (2015-2023) ($MN) 358
TABLE 116 ROW  CELL ANALYSIS MARKET REVENUE, BY CONSUMABLES, (2015-2023) ($MN) 359
TABLE 117 ROW  CELL ANALYSIS MARKET REVENUE, BY INSTRUMENTS, (2015-2023) ($MN)  360
TABLE 118 ROW  CELL ANALYSIS MARKET REVENUE,  BY PROCESS OF APPLICATIONS, (2015-2023) ($MN)  361
TABLE 119 ROW CELL ANALYSIS MARKET REVENUE,  BY FIELD APPLICATIONS, (2015-2023) ($MN)  362
TABLE 120 ROW CELL ANALYSIS MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATION, (2015-2023) ($MN)  363
TABLE 121 ROW CELL ANALYSIS MARKET REVENUE, BY ENDUSERS,  (2015-2023) ($MN) 364
TABLE 122 NEW PRODUCT LAUNCH (2015-2016) 367
TABLE 123 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES (2015-2016) 382
TABLE 124 MERGERS AND ACQUITIONS (2015-2016) 389
TABLE 125 APPROVALS (2015-2016) 393
TABLE 126 BUSINESS EXPANSION (2015-2016) 395
TABLE 127 AGILENT TECHNOLOGIES: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN) 398
TABLE 128 AGILENT TECHNOLOGIES: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN) 399
TABLE 129 AGILENT TECHNOLOGIES: TOTAL REVENUE,  BY GEOGRAPHY, (2014-2016) ($MN) 400
TABLE 130 BECTON DICKINSON AND COMPANY: TOTAL REVENUE AND  R&D EXPENSES, (2014-2016) ($MN) 413
TABLE 131 BECTON DICKINSON AND COMPANY: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN) 414
TABLE 132 BECTON DICKINSON AND COMPANY: TOTAL REVENUE, BY LIFE SCIENCE SEGMENTS, (2014-2016) ($MN) 415
TABLE 133 BECTON DICKINSON AND COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN) 416
TABLE 134 BIO-RAD LABORATORIES: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN) 424
TABLE 135 BIO-RAD LABORATORIES: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN) 425
TABLE 136 BIO-RAD LABORATORIES: TOTAL REVENUE,  BY GEOGRAPHY, (2014-2016) ($MN) 426
TABLE 137 DANAHER CORPORATION: TOTAL REVENUE AND  R&D EXPENSES, (2014-2016) ($MN) 434
TABLE 138 DANAHER CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN) 435
TABLE 139 DANAHER CORPORATION: TOTAL REVENUE,  BY GEOGRAPHY, (2014-2016) ($MN) 436
TABLE 140 GE: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN) 447
TABLE 141 GE: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN) 448
TABLE 142 GE: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN) 449
TABLE 143 MERCK KGAA: TOTAL REVENUE AND  R&D EXPENSES, (2014-2016) ($MN) 459
TABLE 144 MERCK KGAA: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN) 460
TABLE 145 MERCK KGAA: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN) 461
TABLE 146 OLYMPUS CORPORATION : TOTAL REVENUE AND  R&D EXPENSES  (2014-2016) ($MN) 470
TABLE 147 OLYMPUS CORPORATION : TOTAL REVENUE,  BY SEGMENTS (2014-2016) ($MN) 471
TABLE 148 OLYMPUS CORPORATION : TOTAL REVENUE,  BY GEOGRAPHY (2014-2016) ($MN) 472
TABLE 149 PERKINELMER, INC.: TOTAL REVENUE AND R&D EXPENSES  (2014-2016) ($MN) 480
TABLE 150 PERKINELMER, INC.: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN) 481
TABLE 151 PERKINELMER, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN) 482
TABLE 152 PROMEGA CORPORATION: TOTAL REVENUE AND  R&D EXPENSES, (2013-2015) ($MN) 490
TABLE 153 QIAGEN N.V.: TOTAL REVENUE AND  R&D EXPENSES, (2014-2016) ($MN) 499
TABLE 154 QIAGEN N.V.: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN) 500
TABLE 155 QIAGEN N.V.: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN) 501
TABLE 156 THERMOFISHER SCIENTIFIC, INC.: TOTAL REVENUE AND  R&D EXPENSES (2014-2016) ($MN) 516
TABLE 157 THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN) 517
TABLE 158 THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN) 518

LIST OF FIGURES

FIGURE 1 CELL ANALYSIS GLOBAL MARKET REVENUE,  BY GEOGRAPHY (2015-2023) 30
FIGURE 2 RESEARCH METHODOLOGY: CELL ANALYSIS GLOBAL MARKET 46
FIGURE 3 CELL ANALYSIS GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH 47
FIGURE 4 CELL ANALYSIS GLOBAL MARKET: FORECASTING MODEL 48
FIGURE 5 CELL ANALYSIS GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION 49
FIGURE 6 CELL ANALYSIS GLOBAL MARKET: MARKET SEGMENTATION 57
FIGURE 7 MARKET DYNAMICS 58
FIGURE 8 CELL ANALYSIS GLOBAL MARKET: PORTERíS ANALYSIS 74
FIGURE 9 CELL ANALYSIS GLOBAL MARKET: SUPPLY CHAIN ANALYSIS 87
FIGURE 10 CELL ANALYSIS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016 90
FIGURE 11 SINGLE CELL ANALYSIS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016 94
FIGURE 12 CELL ANALYSIS GLOBAL MARKET REVENUE, BY TECHNIQUE  (2015-2023) ($MN) 98
FIGURE 13 CELL ANALYSIS GLOBAL MARKET REVENUE,  BY MOLECULAR APPROACHES OF TECHNIQUE (2016 VíS 2023) ($MN) 102
FIGURE 14 MICROFLUIDICS AND MICROARRAY CELL ANALYSIS GLOBAL MARKET REVENUE,  BY TYPE (2016-2023) ($MN) 115
FIGURE 15 CELL ANALYSIS GLOBAL MARKET REVENUE, BY IMAGE-BASED APPROACHES OF TECHNIQUES (2016 VíS 2023) ($ MN) 130
FIGURE 16 CELL ANALYSIS GLOBAL MARKET, BY PRODUCT, (2015-2023), ($MN) 157
FIGURE 17 CELL ANALYSIS GLOBAL MARKET, BY CONSUMABLES, (2015 VíS 2023), ($MN) 159
FIGURE 18 CELL ANALYSIS GLOBAL MARKET, BY INSTRUMENTS, (2015-2023), ($MN) 175
FIGURE 19 CELL ANALYSIS GLOBAL MARKET REVENUE, BY PROCESS OF APPLICATION (2016 VíS 2023) ($MN) 229
FIGURE 20 CELL ANALYSIS GLOBAL MARKET, BY FIELD OF APPLICATION  (2016 VíS 2023) ($MN) 248
FIGURE 21 CELL ANALYSIS GLOBAL MARKET, BY THERAPEUTIC AREA OF APPLICATION (2016 VíS 2023) ($MN) 265
FIGURE 22 CELL ANALYSIS GLOBAL MARKET REVENUE, BY END USERS  (2016 VíS 2023) ($MN) 280
FIGURE 23 CELL ANALYSIS MARKET GLOBAL REVENUE, BY REGION  (2015-2023) ($MN) 296
FIGURE 24 OUTLOOK OF NORTH AMERICAN MARKET SIZE, BY TECHNIQUES, PRODUCTS,& END-USERS (2016 VíS 2023) 300
FIGURE 25 OUTLOOK OF NORTH AMERICAN MARKET SIZE, BY APPLICATIONS, (2016 VíS 2023) 301
FIGURE 26 OUTLOOK OF EUROPEAN MARKET SIZE, BY PRODUCTS, TECHNIQUES & END-USERS (2016 VíS 2023) 317
FIGURE 27 OUTLOOK OF EUROPEAN MARKET SIZE, BY APPLICATIONS  (2016 VíS 2023) 318
FIGURE 28 OUTLOOK OF ASIA PACIFIC MARKET SIZE, BY PRODUCTS, TECHNIQUES & END-USERS (2016 VíS 2023) 335
FIGURE 29 OUTLOOK OF ASIA PACIFIC MARKET SIZE, BY APPLICATIONS  (2016 VíS 2023) 336
FIGURE 30 OUTLOOK OF ROW CELL ANALYSIS MARKET SIZE, BY PRODUCTS, TECHNIQUES & END-USERS (2016 VíS 2023) 352
FIGURE 31 OUTLOOK OF ROW CELL ANALYSIS MARKET SIZE, BY APPLICATIONS  (2016 VíS 2023) 353
FIGURE 32 KEY GROWTH STRATEGIES (2015-2016) 365
FIGURE 33 SWOT: AGILENT TECHNOLOGIES 411
FIGURE 34 SWOT: BECTON DICKINSON AND COMPANY 422
FIGURE 35 SWOT: BIO-RAD LABORATORIES 432
FIGURE 36 SWOT: DANAHER CORPORATION 445
FIGURE 37 SWOT: GE HEALTHCARE 457
FIGURE 38 SWOT: MERCK KGAA 468
FIGURE 39 SWOT: OLYMPUS CORPORATION 478
FIGURE 40 SWOT: PERKINELMER, INC 488
FIGURE 41 SWOT: PROMEGA CORPORATION 497
FIGURE 42 SWOT: QIAGEN N V 514
FIGURE 43 SWOT:THERMOFISHER SCIENTIFIC 525

If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.